Oruka Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-8.3M | $-8.3M | $4.0K | $458.0K |
| FY2011 | $-7.0M | $-7.0M | $19.0K | $308.0K |
| FY2012 | $-4.1M | $-4.1M | — | $306.0K |
| FY2013 | $-5.3M | $-5.3M | $32.0K | $283.0K |
| FY2014 | $-9.4M | $-9.4M | $19.0K | $647.0K |
| FY2015 | $-10.5M | $-10.5M | $11.0K | $599.0K |
| FY2016 | $-15.0M | $-15.0M | $12.0K | $576.0K |
| FY2017 | $-17.5M | $-17.5M | $3.0K | $458.0K |
| FY2018 | $-8.2M | $-8.2M | $4.0K | $273.0K |
| FY2019 | $-4.8M | $-4.8M | $4.0K | $151.0K |
| FY2020 | $-7.7M | $-7.7M | $19.0K | $43.0K |
| FY2021 | $-18.8M | $-18.8M | $43.0K | $497.0K |
| FY2022 | $-10.9M | $-10.9M | $2.0K | $556.0K |
| FY2023 | $-5.0M | $-5.0M | $0 | $686.0K |
| FY2024 | $-57.8M | $-58.0M | $189.0K | $14.9M |
| FY2025 | $-88.2M | $-88.4M | $209.0K | $24.2M |